Home
NCT Heidelberg

NCT Heidelberg Market Share Analysis for November 2025

Das Nationale Centrum für Tumorerkrankungen in Heidelberg ist eine onkologische Tagesklinik mit einer Tumorambulanz.

Health > Health Conditions and Concerns

Domainnct-heidelberg.de

Year Founded2004

Employees201 - 500

Annual Revenue$50M - $75M

NCT Heidelberg

NCT Heidelberg (including company regionals)

nct-heidelberg.de

See more website traffic and engagement information

NCT Heidelberg Revenue up to November 2025 is 50M - 75M

revenue generated by NCT Heidelberg top domains

NCT Heidelberg top domains revenue over 3 years

Revenue for NCT Heidelberg top domains

nct-heidelberg.de50M - 75M

See more with Sales Intelligence

Total visits to NCT Heidelberg's top domains

Understand NCT Heidelberg market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nct-heidelberg.de22.9K

See more with Sales Intelligence

Avg. visit duration in NCT Heidelberg's top domains

Analyze NCT Heidelberg engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nct-heidelberg.de00:01:50

See more with Sales Intelligence

Avg. pageviews on NCT Heidelberg's top domains

See how NCT Heidelberg keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nct-heidelberg.de2.16

See more with Sales Intelligence

NCT Heidelberg top competitors by domain

Top similar sites in November 2025, ranked by their affinity

bayerische-krebsgesellschaft.deCompany NameBayerische Krebsgesellschaft e.V.Employees51 - 200HQGermany, munichAnnual revenue$2M - $5MTotal visits7.5KHealth > Health Conditions and Concerns

Top technologies used by NCT Heidelberg

These are the website technologies, by industry, used by NCT Heidelberg top domains

Payment & Currencies (23)

PayPal

Social (5)

Instagram

Widget (4)

Google Maps

Audio Video Media (3)

YouTube

More Technologies

9

See all

News & Signals from NCT Heidelberg

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNCT Heidelberg is developing CAR T vector system.Proteona, a Singapore-based single-cell precision medicine company, has announced the publication of the results of a long-term collaboration with researchers at the German Cancer Research Center (DKFZ) and its National Center for Tumor Diseases (NCT) to develop and characterize an innovative non-integrating CAR T vector system.

NewsProtagen AG partnered with NCT Heidelberg on Sep 26th '18.Protagen announced today a collaboration with the National Center for Tumor Diseases (NCT) Heidelberg to identify biomarkers for predicting therapeutic response and immune-related adverse events (irAEs) in urothelial carcinoma patients receiving checkpoint-inhibitor immunotherapy.